GlaxoSmithKline tries flat curve test case with defensive deal tailor made for crisis
GlaxoSmithKline, the UK pharmaceutical company, launched a three tranche bond issue on Monday. Its sterling curve was trading so flat that it started with the same spread on the long eight and 15 year tranches.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: